Lowering apolipoprotein C-III associates with regression of lipidic plaque materials in type 2 DM patients with coronary artery disease: the pre-specified analysis from the OPTIMAL trial

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Young Investigator Awards Session in Clinical Cardiology Lipids ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by